No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
Jean‐Michel Molina, Constance Delaugerre, J. Le Goff, B. Mela-Lima, D. Ponscarme, Lauriane Goldwirt, Nathalie De Castro
Topics & Concepts
HydroxychloroquineAzithromycinCoronavirus disease 2019 (COVID-19)MedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakVirologyIntensive care medicineInternal medicineBiologyAntibioticsMicrobiologyInfectious disease (medical specialty)OutbreakDiseaseCOVID-19 Clinical Research StudiesInfectious Encephalopathies and EncephalitisSARS-CoV-2 and COVID-19 Research